According to the new market research report “Cell Therapy Technologies Market by Product (Consumables, Equipment, Software), Cell Type (Human Stem & Differentiated, Animal), Process Stages (Cell Processing, Distribution, Handling, QC), End User, and Region - Global Forecast to 2023", published by MarketsandMarkets™, The Cell Therapy Technologies Market is projected to reach USD 19.9 billion by 2023 from USD 10.2 billion in 2018, at a CAGR of 14.4%. Factors such as rising governent investments for cell-based research, the increasing number of GMP-certified production facilities, and the large number of oncology-oriented cell-based therapy clinical trials are driving the growth of this market.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=213334978
Rising government investments for cell-based research, the increasing number of GMP-certified production facilities, and the large number of oncology-oriented cell-based therapy clinical trials are the key factors driving the growth of this market. China, India, Japan, Korea, and Brazil are emerging markets for cell therapy instruments.
These markets boast comparatively lenient standards and government regulations as opposed to developed markets in North America and the EU, and thus offer significant growth potential for providers. However, the high cost of cell-based research and the low success rate is expected to restrain market growth to some extent during the forecast period.
Browse and in-depth TOC on “Cell Therapy Technologies Market”
75 - Tables
30 - Figures
116 - Pages
Key Market Players
Key players in this market include Beckman Coulter (US), Becton, Dickinson and Company (US), GE Healthcare (US), Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Terumo BCT (US), and Thermo Fisher Scientific (US).
Thermo Fisher was the largest player in the cell therapy technologies market in 2017. In order to maintain its position in the market and further expand its product portfolio, the company focuses on the strategies of product launches, acquisitions, and expansions. Merck holds the second position in the cell therapy technologies market. The company focuses on collaborations, agreements, and acquisitions to enhance its market position.
Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=213334978
Cell Therapy Technologies Market worth $19.9 billion by 2023
Cell Therapy Technologies Global Market Report 2021 by The Business Research Company is the most comprehensive report available on the market, being wide-ranging both in terms of chronology and geography.
The report helps gain a truly global perspective as it covers 60 geographies, focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.TBRC’s market report includes a chapter on the COVID-19 impact on the cell therapy technologies industry, which gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market and how companies can strategize to bounce back from it.
With updated market numbers according to the effects of the coronavirus, the report provides the most accurate expected cell therapy technologies market growth numbers from 2021-2030.Request a Sample of the report:https://www.thebusinessresearchcompany.com/sample.aspx?id=4122=smpThe global cell therapy technologies market is expected to grow from $2.36 billion in 2020 to $2.96 billion in 2021 at a compound annual growth rate (CAGR) of 25.4%.
The growth is mainly due to an increase in investments in cell therapies and the growth in research and development for cell therapy.
The cell therapy technologies market is expected to reach $5.57 billion in 2025 at a CAGR of 17.1%.View more on the report:https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-reportThe Cell Therapy Technologies Global Market Report 2020-30 by The Business Research Company evaluates cell therapy technologies market size, growth rate, drivers, cell therapy technologies industry trends, and major companies.Cell therapy technologies market segments in the report are:1) By Product: Consumables, Equipment, Systems & Software2) By Cell Type: T-Cells, Stem Cells, Other Cells3) By Process: Cell Processing, Cell Preservation, Distribution And Handling, Process Monitoring And Quality Control4) By End-User: Life Science Companies, Research InstitutesThe table of contents in TBRC’s cell therapy technologies market report includes:1.
Competitive Landscape And Company Profiles28.
Factors such as the growing awareness related to the therapeutic potency of stem cells in disease management, development of advanced genome-based cell analysis techniques, increasing public-private investments for stem cell research, identification of new stem cell lines, and developments in infrastructure for stem cell banking and processing are propelling the growth of the global stem cell therapy market.The Stem Cell Therapy Market is expected to reach USD 161.8 million by 2022, growing at a CAGR of 11.0% during the forecast period.Product AnalysisProduct Matrix which gives a detailed comparison of the product portfolios of the top five companiesGeographical AnalysisFurther breakdown of the North American stem cell therapy market into the US and CanadaFurther breakdown of the European stem cell therapy market into the UK, Germany, France, and Rest of EuropeCompany InformationDetailed analysis and profiling of additional market players (Up to 5)Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=48 On the basis of therapeutic application, the global stem cell therapy market is segmented into musculoskeletal disorders, wounds and injuries, cardiovascular diseases, surgeries, gastrointestinal diseases, and other applications.
This large share can be attributed to the rising availability of stem cell-based products for the treatment of musculoskeletal disorders, high prevalence of musculoskeletal disorders and bone & joint diseases, and growing patient preference for effective & early treatment strategies.On the basis of cell source, the global stem cell therapy market is divided into adipose derived MSCs; bone marrow derived MSCs, embryonic / cord blood SCs, and other cell sources.
The adipose derived MSCs segment was expected to account for the largest share of 59.1% in the global stem cell therapy market in 2017.
Furthermore, the bone marrow derived MSCs segment is expected to grow at highest CAGR of 12.1% during the forecast period.Read more (Stem Cell Therapy Market):-https://www.marketsandmarkets.com/PressReleases/stem-cells-market.aspThe Major Players in this Market:As of 2016, Osiris Therapeutics, Inc. (U.S.), MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), Pharmicell Co., Ltd. (South Korea), Holostem Terapie Avanzate S.r.l.
(Italy), JCR Pharmaceuticals Co., Ltd. (Japan), NuVasive, Inc. (U.S.), RTI Surgical, Inc. (U.S.), and AlloSource (U.S.) were some of the key players operating in the global stem cell therapy market.
About MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.
Cell Therapy Technologies Global Market Report 2021 by The Business Research Company is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The chapter on the impact – both negative and positive – of COVID-19 on the cell therapy technologies industry gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.
View Complete Report:https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report The Cell Therapy Technologies Global Market Report 2020-30 by The Business Research Company provides an in-depth analysis of the global cell therapy technologies market and covers both the historic period, 2015 to 2020, and the forecast period, 2020 to 2030.
The report evaluates the market and major economies across the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The global cell therapy technologies market is expected to grow from $2.36 billion in 2020 to $2.96 billion in 2021 at a compound annual growth rate (CAGR) of 25.4%.
The growth is mainly due to an increase in investments in cell therapies and the growth in research and development for cell therapy.
Precise Market Intelligence (PMI) presents its new, comprehensive study on the global Cell Therapy Technologies market spanning from 2020 to 2025.
The Researchers at PMI have no left no stone unturned in bestowing readers a comprehensive view of the market, by studying the drivers, trends, challenges, and restraints.
Backed by historical data and projected data, the report breaks down the vast study into numerous geographies and end-use segments, among others to condense the research.
The report also considers production and consumption analysis, value chain analysis, key findings, important suggestions and recommendations, and other aspects.
Ranging from macro socio-economic factors to micro geography-specific trends, the research has taken into consideration every facet that is likely to play a vital role in the growth of the market in the years to come.
Presenting a plethora of valuable information, the report will serve as an effective tool, guiding the market players in making fruitful decisions in the forthcoming years.For More Insights Into The Market, Request a Sample of This Report@ https://www.precisemarketintelligence.com/sample/81Impact of COVID-19 on Cell Therapy Technologies MarketThe unforeseen outbreak of COVID-19, which swiftly metamorphosed into the pandemic of unexpected proportions, has shifted the world’s focus towards the healthcare sector.
Cell Therapy Technologies Global Market Report 2021 by The Business Research Company is the most comprehensive report available on the market, being wide-ranging both in terms of chronology and geography.
The report helps gain a truly global perspective as it covers 60 geographies, focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.TBRC’s market report includes a chapter on the COVID-19 impact on the cell therapy technologies industry, which gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market and how companies can strategize to bounce back from it.
With updated market numbers according to the effects of the coronavirus, the report provides the most accurate expected cell therapy technologies market growth numbers from 2021-2030.Request a Sample of the report:https://www.thebusinessresearchcompany.com/sample.aspx?id=4122=smpThe global cell therapy technologies market is expected to grow from $2.36 billion in 2020 to $2.96 billion in 2021 at a compound annual growth rate (CAGR) of 25.4%.
The growth is mainly due to an increase in investments in cell therapies and the growth in research and development for cell therapy.
The cell therapy technologies market is expected to reach $5.57 billion in 2025 at a CAGR of 17.1%.View more on the report:https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-reportThe Cell Therapy Technologies Global Market Report 2020-30 by The Business Research Company evaluates cell therapy technologies market size, growth rate, drivers, cell therapy technologies industry trends, and major companies.Cell therapy technologies market segments in the report are:1) By Product: Consumables, Equipment, Systems & Software2) By Cell Type: T-Cells, Stem Cells, Other Cells3) By Process: Cell Processing, Cell Preservation, Distribution And Handling, Process Monitoring And Quality Control4) By End-User: Life Science Companies, Research InstitutesThe table of contents in TBRC’s cell therapy technologies market report includes:1.
Competitive Landscape And Company Profiles28.
Factors such as the growing awareness related to the therapeutic potency of stem cells in disease management, development of advanced genome-based cell analysis techniques, increasing public-private investments for stem cell research, identification of new stem cell lines, and developments in infrastructure for stem cell banking and processing are propelling the growth of the global stem cell therapy market.The Stem Cell Therapy Market is expected to reach USD 161.8 million by 2022, growing at a CAGR of 11.0% during the forecast period.Product AnalysisProduct Matrix which gives a detailed comparison of the product portfolios of the top five companiesGeographical AnalysisFurther breakdown of the North American stem cell therapy market into the US and CanadaFurther breakdown of the European stem cell therapy market into the UK, Germany, France, and Rest of EuropeCompany InformationDetailed analysis and profiling of additional market players (Up to 5)Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=48 On the basis of therapeutic application, the global stem cell therapy market is segmented into musculoskeletal disorders, wounds and injuries, cardiovascular diseases, surgeries, gastrointestinal diseases, and other applications.
This large share can be attributed to the rising availability of stem cell-based products for the treatment of musculoskeletal disorders, high prevalence of musculoskeletal disorders and bone & joint diseases, and growing patient preference for effective & early treatment strategies.On the basis of cell source, the global stem cell therapy market is divided into adipose derived MSCs; bone marrow derived MSCs, embryonic / cord blood SCs, and other cell sources.
The adipose derived MSCs segment was expected to account for the largest share of 59.1% in the global stem cell therapy market in 2017.
Furthermore, the bone marrow derived MSCs segment is expected to grow at highest CAGR of 12.1% during the forecast period.Read more (Stem Cell Therapy Market):-https://www.marketsandmarkets.com/PressReleases/stem-cells-market.aspThe Major Players in this Market:As of 2016, Osiris Therapeutics, Inc. (U.S.), MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), Pharmicell Co., Ltd. (South Korea), Holostem Terapie Avanzate S.r.l.
(Italy), JCR Pharmaceuticals Co., Ltd. (Japan), NuVasive, Inc. (U.S.), RTI Surgical, Inc. (U.S.), and AlloSource (U.S.) were some of the key players operating in the global stem cell therapy market.
About MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.
Cell Therapy Technologies Global Market Report 2021 by The Business Research Company is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The chapter on the impact – both negative and positive – of COVID-19 on the cell therapy technologies industry gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.
View Complete Report:https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report The Cell Therapy Technologies Global Market Report 2020-30 by The Business Research Company provides an in-depth analysis of the global cell therapy technologies market and covers both the historic period, 2015 to 2020, and the forecast period, 2020 to 2030.
The report evaluates the market and major economies across the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The global cell therapy technologies market is expected to grow from $2.36 billion in 2020 to $2.96 billion in 2021 at a compound annual growth rate (CAGR) of 25.4%.
The growth is mainly due to an increase in investments in cell therapies and the growth in research and development for cell therapy.
Precise Market Intelligence (PMI) presents its new, comprehensive study on the global Cell Therapy Technologies market spanning from 2020 to 2025.
The Researchers at PMI have no left no stone unturned in bestowing readers a comprehensive view of the market, by studying the drivers, trends, challenges, and restraints.
Backed by historical data and projected data, the report breaks down the vast study into numerous geographies and end-use segments, among others to condense the research.
The report also considers production and consumption analysis, value chain analysis, key findings, important suggestions and recommendations, and other aspects.
Ranging from macro socio-economic factors to micro geography-specific trends, the research has taken into consideration every facet that is likely to play a vital role in the growth of the market in the years to come.
Presenting a plethora of valuable information, the report will serve as an effective tool, guiding the market players in making fruitful decisions in the forthcoming years.For More Insights Into The Market, Request a Sample of This Report@ https://www.precisemarketintelligence.com/sample/81Impact of COVID-19 on Cell Therapy Technologies MarketThe unforeseen outbreak of COVID-19, which swiftly metamorphosed into the pandemic of unexpected proportions, has shifted the world’s focus towards the healthcare sector.